Published in Infect Immun on April 01, 1992
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect Immun (2004) 1.25
Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol (1995) 1.24
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun (2001) 1.19
Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun (1993) 1.19
Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J Clin Microbiol (1996) 1.16
Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect Immun (2002) 1.13
Variation in flagellin genes and proteins of Burkholderia cepacia. J Bacteriol (1998) 1.13
Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect Immun (2003) 1.08
Group A streptococci bind to mucin and human pharyngeal cells through sialic acid-containing receptors. Infect Immun (2001) 1.05
Barrier function of airway tract epithelium. Tissue Barriers (2013) 1.02
A murine model for infection with Burkholderia cepacia with sustained persistence in the spleen. Infect Immun (1999) 1.00
Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr (1998) 0.99
Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium. Infect Immun (2005) 0.98
Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect Immun (1996) 0.97
The level of expression of the minor pilin subunit, CooD, determines the number of CS1 pili assembled on the cell surface of Escherichia coli. J Bacteriol (1999) 0.96
Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol (2015) 0.91
Genetic characterization of a multicomponent signal transduction system controlling the expression of cable pili in Burkholderia cenocepacia. J Bacteriol (2004) 0.89
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex. J R Soc Med (2000) 0.88
Adhesion of human enterotoxigenic Escherichia coli to human mucus secreting HT-29 cell subpopulations in culture. Gut (1994) 0.87
Transcriptional and posttranscriptional control of cable pilus gene expression in Burkholderia cenocepacia. J Bacteriol (2004) 0.86
Mechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial Cells. Front Cell Infect Microbiol (2015) 0.83
Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol (2012) 0.82
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem (1984) 22.53
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem (1984) 5.85
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis (1985) 3.71
Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol Gen Genet (1987) 3.59
Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun (1990) 2.94
Colonization and infection with Pseudomonas cepacia. J Infect Dis (1972) 2.91
Biochemical studies on pili isolated from Pseudomonas aeruginosa strain PAO. Can J Microbiol (1979) 2.08
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Mapping of the antigenic determinants of Pseudomonas aeruginosa PAK polar pili. Infect Immun (1983) 1.73
Structure of polar pili from Pseudomonas aeruginosa strains K and O. J Mol Biol (1981) 1.59
Inhibition of pilus-mediated adhesion of Pseudomonas aeruginosa to human buccal epithelial cells by monoclonal antibodies directed against pili. Infect Immun (1990) 1.54
Antigenic and structural features of goblet-cell mucin of human small intestine. Biochem J (1984) 1.48
Hyperadhesive mutant of type 1-fimbriated Escherichia coli associated with formation of FimH organelles (fimbriosomes). Infect Immun (1988) 1.44
Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.44
The putative 'link' glycopeptide associated with mucus glycoproteins. Composition and properties of preparations from the gastrointestinal tracts of several mammals. Biochem J (1989) 1.33
Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun (1990) 1.27
Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol (1975) 1.25
Radioimmunoassay of human intestinal goblet cell mucin. Investigation of mucus from different organs and species. J Clin Invest (1979) 1.24
Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med (1975) 1.16
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Intestinal mucins in health and disease. Digestion (1978) 1.94
Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80
Goblet cell mucin of rat small intestine. Chemical and physical characterization. Can J Biochem (1973) 1.55
Antigenic and structural features of goblet-cell mucin of human small intestine. Biochem J (1984) 1.48
Heterogeneity of rat goblet-cell mucin before and after reduction. Biochem J (1983) 1.42
Biochemical characterization of the component parts of intestinal mucin from patients with cystic fibrosis. Biochem J (1984) 1.40
Vibrio cholerae metalloproteinase degrades intestinal mucin and facilitates enterotoxin-induced secretion from rat intestine. Biochim Biophys Acta (1987) 1.33
The putative 'link' glycopeptide associated with mucus glycoproteins. Composition and properties of preparations from the gastrointestinal tracts of several mammals. Biochem J (1989) 1.33
cDNA for the carboxyl-terminal region of a rat intestinal mucin-like peptide. J Biol Chem (1992) 1.28
Characteristics of binding of Escherichia coli serotype O157:H7 strain CL-49 to purified intestinal mucin. Infect Immun (1990) 1.28
Radioimmunoassay of human intestinal goblet cell mucin. Investigation of mucus from different organs and species. J Clin Invest (1979) 1.24
Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol (1995) 1.24
Characterization and localization of the putative 'link' component in rat small-intestinal mucin. Biochem J (1987) 1.20
Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun (2000) 1.20
Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun (1993) 1.19
Enhancement of the viscosity of mucin by serum albumin. Biochem J (1978) 1.14
The T84 human colonic adenocarcinoma cell line produces mucin in culture and releases it in response to various secretagogues. Biochem J (1990) 1.08
P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Antimicrob Agents Chemother (2001) 1.08
The role of disulphide bonds in human intestinal mucin. Biochem J (1979) 1.05
Effects of calcium on intestinal mucin: implications for cystic fibrosis. Pediatr Res (1976) 1.01
Synthesis and secretion of mucin by the human colonic tumour cell line LS180. Biochem J (1994) 1.01
Intestinal mucins inhibit rotavirus replication in an oligosaccharide-dependent manner. J Infect Dis (1994) 0.99
Cholera toxin stimulates secretion of immunoreactive intestinal mucin. Am J Physiol (1981) 0.98
Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect Immun (1996) 0.97
Calcium binding to intestinal goblet cell mucin. Biochim Biophys Acta (1975) 0.96
Evidence that a peptide corresponding to the rat Muc2 C-terminus undergoes disulphide-mediated dimerization. Eur J Biochem (1998) 0.96
Radioimmunoassay of intestinal goblet cell mucin. Anal Biochem (1977) 0.95
Role of the putative "link" glycopeptide of intestinal mucin in binding of piliated Escherichia coli serotype O157:H7 strain CL-49. Infect Immun (1990) 0.93
Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol (1997) 0.92
Adherence to lipids and intestinal mucin by a recently recognized human pathogen, Campylobacter upsaliensis. Infect Immun (1996) 0.91
The carboxyl-terminal sequence of rat intestinal mucin RMuc3 contains a putative transmembrane region and two EGF-like motifs. Biochim Biophys Acta (1997) 0.91
Role of the cystine-knot motif at the C-terminus of rat mucin protein Muc2 in dimer formation and secretion. Biochem J (2001) 0.88
Regulated and unregulated pathways for MUC2 mucin secretion in human colonic LS180 adenocarcinoma cells are distinct. Biochem J (1995) 0.86
Susceptibility of the cysteine-rich N-terminal and C-terminal ends of rat intestinal mucin muc 2 to proteolytic cleavage. Biochem J (1998) 0.86
Characteristics of rodent intestinal mucin Muc3 and alterations in a mouse model of human cystic fibrosis. Am J Physiol Gastrointest Liver Physiol (2001) 0.85
The effects of delipidation on the major antigenic determinant of purified human intestinal mucin. Biochem Cell Biol (1986) 0.85
Protein kinase C-epsilon is the likely mediator of mucin exocytosis in human colonic cell lines. Am J Physiol (1997) 0.85
Structural and compositional differences between intracellular and secreted mucin of rat small intestine. Biochem J (1987) 0.85
Suggestive evidence for two different mucin genes in rat intestine. Biochem J (1993) 0.84
Radiation inactivation of human intestinal mucin: determination of the size of the functional antigenic unit. Biochim Biophys Acta (1986) 0.83
Purification and characterization of a novel protein produced by Bifidobacterium longum SBT2928 that inhibits the binding of enterotoxigenic Escherichia coli Pb176 (CFA/II) to gangliotetraosylceramide. J Appl Microbiol (1999) 0.83
The cationic C-terminus of rat Muc2 facilitates dimer formation post translationally and is subsequently removed by furin. Eur J Biochem (2000) 0.83
Epithelial response to intestinal anaphylaxis in rats: goblet cell secretion and enterocyte damage. Am J Physiol (1984) 0.83
Interaction of mucins with calcium, H+ ion and albumin. Mod Probl Paediatr (1978) 0.82
Roles of calreticulin and calnexin during mucin synthesis in LS180 and HT29/A1 human colonic adenocarcinoma cells. Biochem J (1999) 0.82
Structure of intestinal-mucus glycoprotein from human post-mortem or surgical tissue: inferences from correlation analyses of sugar and sulfate composition of individual mucins. Carbohydr Res (1983) 0.80
Tissue-specific expression of a rat intestinal mucin-like peptide. Biochem J (1992) 0.79
Cloning of the cDNA for a rat intestinal Na+/dicarboxylate cotransporter reveals partial sequence homology with a rat intestinal mucin. Biochim Biophys Acta (1996) 0.78
Differences in mucus glycoproteins of small intestine from subjects with and without cystic fibrosis. Adv Exp Med Biol (1982) 0.78
Factors affecting the synthesis of 2,3-diphosphoglycerate in hemolysates of human erythrocytes. Biochim Biophys Acta (1968) 0.78
Stimulation of proteolytic digestion by intestinal goblet cell mucus. Gastroenterology (1975) 0.77
Purification and immunofluorescent localization of rat submandibular mucin. Biochem J (1982) 0.75
Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins. Glycoconj J (1996) 0.75
Mucin domains to explore disulfide-dependent dimer formation. Methods Mol Biol (2000) 0.75
The use of radioimmunoassay as a probe of the antigenic determinants and structure of human small intestinal mucin. Adv Exp Med Biol (1982) 0.75
Radioimmunoassay of rat submandibular salivary gland mucin. Arch Oral Biol (1983) 0.75